Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01722643 · ClinicalTrials.gov registry record · NA

Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT01722643 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 61 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01722643, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

The overall goal of this project is to develop a novel family friendly intervention that will help teens with poor metabolic control of their type 1 diabetes increase and sustain daily self monitoring of blood glucose and lower HbA1c. This is important because poor metabolic control has long-term health implications. This project will provide important information regarding new effective ways to improve outcomes among teens with poorly controlled type 1 diabetes. Primary hypotheses are that the intervention, MAxIM, will: (1) help teens improve and maintain glucose control, and (2) improve decision making (improve executive function and reduce delay discounting), which will predict treatment outcome.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL MAxIM

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2014-01
Est. Completion 2016-09
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT01722643

The ClinicalTrials.gov registry entry for NCT01722643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT01722643 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01722643 about?

NCT01722643 is a clinical study titled "Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes". The overall goal of this project is to develop a novel family friendly intervention that will help teens with poor metabolic control of their type 1 diabetes increase and sustain daily self monitoring of blood glucose and lower HbA1c. This is important because poor metabolic control has long-term he...

What is the current status of trial NCT01722643?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2014-01. Estimated completion is 2016-09.

What interventions are being tested in trial NCT01722643?

The interventions under investigation include: Usual Care (BEHAVIORAL), MAxIM (BEHAVIORAL).

Who is sponsoring clinical trial NCT01722643?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.